Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic: A Global Time Series Study.

ABSTRACT:

Background

Drug supply disruptions have increased during the COVID-19 pandemic, especially for medicines used in the ICU. Despite reported shortages in wealthy countries, global analyses of ICU drug purchasing during COVID-19 are limited.

Research question

Has COVID-19 impacted global drug purchases of first-, second-, and third-choice agents used in intensive care?

Study design and methods

We conducted a cross-sectional time series study in a global pharmacy sales dataset comprising approximately 60% of the world's population. We analyzed pandemic-related changes in units purchased per 1,000 population for 69 ICU agents. Interventional autoregressive integrated moving average models tested for significant changes when the pandemic was declared (March 2020) and during

SUBMITTER: Callaway Kim K 

PROVIDER: S-EPMC8421073 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature